Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
ten Cate
R
R
van Suijlekom-Smit
L W A
LW
Brinkman
D M C
DM
Bekkering
W P
WP
Jansen-van Wijngaarden
C J A
CJ
Vossen
J M
JM
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004351:Drug Resistance; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept